Company Financials

Gilead Sciences, Inc. Financials

United States dollar

business Gilead Sciences, Inc. Company Profile

Main Stock Listing

NASDAQ: GILD

Market Capitalization $138.71 Billion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jul. 4, 2025

Trailing PE 23.43
Forward PE 15.01
Price to Sales TTM $4.83
Price to Book MRQ $7.25
Enterprise to Revenue 5.36
Enterprise to EBITDA 11.23

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-03-31
Profit Margin 20.76%
Operating Margin 38.49%
Return on Assets TTM 12.14%
Return on Equity TTM 32.65%

Income Statement

Revenue TTM $28,735,000,576
Revenue per Share TTM $23.05
Quarterly Revenue Growth -0.30%
Gross Profit TTM $22,496,000,000
EBITDA $13,411,000,000
Net Income to Common TTM $5,965,000,192
Diluted EPS TTM $4.76
Quarterly Earnings Growth YoY -0.28%

Balance Sheet

Total Cash MRQ $8,711,000,064
Total Cash per Share MRQ $7.00
Total Debt MRQ $
Total Debt to Equity MRQ 130.79
Current Ratio MRQ 1.37
Book Value per Share MRQ $15.39

Cash Flow

Operating Cash Flow TTM $10,366,000,128
Levered Free Cash Flow TTM $9,989,000,192

GILD Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding 1,246,265,857
Float Shares 1,241,354,188
Avg 10 Volume 10,443,000
Avg 30 Volume None
Shares Short 22,993,007
Short Ratio 2.85
Short % of Shares 1.85%
% Held by Insiders 0.10%
% Held by Institutions 89.60%

Stock Price Summary

Beta 0.31
Fifty Two Week Low $66.01
Fifty Two Week High $119.96
Fifty Two Week Change 40.32%
Day 50 MA $106.53
Day 200 MA $98.74

Dividends and Splits

Forward Annual Dividend Rate $3.16
Forward Annual Dividend Yield 2.83%
Trailing Annual Dividend Rate $3.12
Trailing Annual Dividend Yield 2.79%
Payout Ratio 65.13%
Dividend Date 2025-06-27
Ex Dividend Date 2025-06-13
Last Split Factor
Last Split Date 2013-01-28